Clinical Trial Update: ADRN Barrier/Immunoprofiling Exploratory Pilot Study

View source ↗

Summary

NIAID completed an exploratory pilot trial examining barrier function and immunoprofiling in dermatitis/atopic dermatitis (eczema), including non-atopic healthy…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Dermatitis, Dermatitis, Atopic | Status: COMPLETED